ARTICLE | Financial News

HalioDx raises first tranche of €18.5M series B

January 19, 2018 5:39 AM UTC

Diagnostic company HalioDx S.A.S. (Marseille, France) raised €9.25 million ($11.3 million) on Jan. 17 in the first tranche of a €18.5 million ($22.6 million) series B round led by new investor PSIM. Other new investors Quest for Growth fund and Amundi Private Equity Funds also participated, as did existing investors MI Care, Sham Innovation Santé/Turenne, BNP Paribas and Sofipaca.

HalioDx Chairman and CEO Vincent Fert told BioCentury he expects to receive the second tranche next year...

BCIQ Company Profiles

HalioDx S.A.S.